| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.569 | 0.011 | 0.569 | GABA C receptor rho-3 antagonist | 0.391 0.065 CID_5897 | ||
| 0.529 | 0.007 | 0.529 | Peroxidase inhibitor | 0.336 0.031 CID_5897 | ||
| 0.525 | 0.006 | 0.525 | Anesthetic general | 0.408 0.015 CID_5897 | ||
| 0.518 | 0.024 | 0.518 | 5 Hydroxytryptamine release stimulant | 0.232 0.099 CID_5897 | ||
| 0.479 | 0.015 | 0.479 | Superoxide dismutase inhibitor | 0.324 0.043 CID_5897 | ||
| 0.483 | 0.042 | 0.518 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.518 0.026 CID_5897 | CID_5897 | |
| 0.439 | 0.005 | 0.439 | Platelet activating factor beta antagonist | 0.196 0.025 CID_5897 | ||
| 0.466 | 0.043 | 0.466 | Calcium channel L-type activator | 0.41 0.074 CID_5897 | ||
| 0.414 | 0.008 | 0.414 | Lipocortins synthesis antagonist | 0.171 0.079 CID_5897 | ||
| 0.438 | 0.039 | 0.438 | MAP kinase kinase 6 inhibitor | 0.273 0.163 CID_5897 | ||
| 0.437 | 0.042 | 0.437 | Aldehyde oxidase inhibitor | 0.159 0.131 CID_5897 | ||
| 0.414 | 0.02 | 0.414 | Sigma receptor agonist | |||
| 0.443 | 0.055 | 0.524 | 5 Hydroxytryptamine release inhibitor | 0.524 0.025 CID_5897 | CID_5897 | |
| 0.384 | 0.01 | 0.384 | Tyrosine 3 hydroxylase inhibitor | 0.325 0.023 CID_5897 | ||
| 0.432 | 0.059 | 0.492 | Histamine release inhibitor | 0.492 0.032 CID_5897 | CID_5897 | |
| 0.387 | 0.02 | 0.387 | Platelet aggregation inhibitor | 0.256 0.049 CID_5897 | ||
| 0.39 | 0.039 | 0.39 | Aryl hydrocarbon receptor agonist | 0.371 0.043 CID_5897 | ||
| 0.363 | 0.013 | 0.363 | Phospholipase C inhibitor | 0.201 0.043 CID_5897 | ||
| 0.435 | 0.091 | 0.535 | Caspase 9 stimulant | 0.535 0.048 CID_5897 | CID_5897 | |
| 0.374 | 0.036 | 0.374 | Calcium channel activator | 0.277 0.117 CID_5897 | ||
| 0.338 | 0.01 | 0.338 | Neurotrophic factor enhancer | 0.253 0.037 CID_5897 | ||
| 0.363 | 0.037 | 0.363 | DNA damaging | 0.261 0.075 CID_5897 | ||
| 0.326 | 0.008 | 0.326 | GABA C receptor agonist | 0.124 0.047 CID_5897 | ||
| 0.359 | 0.042 | 0.386 | Interleukin 2 agonist | 0.386 0.032 CID_5897 | CID_5897 | |
| 0.33 | 0.015 | 0.358 | 5 Hydroxytryptamine 1E antagonist | 0.358 0.008 CID_5897 | CID_5897 | |
| 0.338 | 0.025 | 0.338 | ErbB-1 antagonist | 0.2 0.089 CID_5897 | ||
| 0.327 | 0.026 | 0.327 | MAP kinase kinase 2 inhibitor | 0.227 0.065 CID_5897 | ||
| 0.305 | 0.006 | 0.305 | MAP kinase kinase 3 inhibitor | 0.204 0.111 CID_5897 | ||
| 0.332 | 0.035 | 0.378 | Interleukin agonist | 0.378 0.022 CID_5897 | CID_5897 | |
| 0.299 | 0.011 | 0.299 | Platelet activating factor antagonist | 0.175 0.034 CID_5897 | ||
| 0.298 | 0.013 | 0.298 | Toll-Like receptor 9 antagonist | 0.165 0.053 CID_5897 | ||
| 0.3 | 0.018 | 0.3 | NOS3 expression enhancer | 0.299 0.018 CID_5897 | ||
| 0.285 | 0.004 | 0.285 | MAP3K9 inhibitor | 0.235 0.007 CID_5897 | ||
| 0.317 | 0.037 | 0.317 | 5 Hydroxytryptamine uptake stimulant | 0.247 0.084 CID_5897 | ||
| 0.315 | 0.039 | 0.315 | DNA synthesis inhibitor | 0.207 0.112 CID_5897 | ||
| 0.306 | 0.039 | 0.306 | Anticonvulsant | 0.167 0.11 CID_5897 | ||
| 0.292 | 0.026 | 0.292 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.239 0.047 CID_5897 | ||
| 0.295 | 0.035 | 0.295 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.354 | 0.097 | 0.354 | 15-Lipoxygenase inhibitor | 0.261 0.156 CID_5897 | ||
| 0.259 | 0.005 | 0.259 | HIV-1 integrase (Overall Integration) inhibitor | 0.128 0.035 CID_5897 | ||
| 0.26 | 0.005 | 0.26 | GABA C receptor antagonist | 0.124 0.049 CID_5897 | ||
| 0.288 | 0.034 | 0.288 | RNA-directed DNA polymerase inhibitor | 0.194 0.109 CID_5897 | ||
| 0.274 | 0.028 | 0.274 | LIM domain kinase 1 inhibitor | 0.231 0.048 CID_5897 | ||
| 0.25 | 0.009 | 0.25 | Carbonic anhydrase III inhibitor | 0.213 0.014 CID_5897 | ||
| 0.282 | 0.043 | 0.282 | Death-associated protein kinase 3 inhibitor | 0.194 0.078 CID_5897 | ||
| 0.256 | 0.018 | 0.256 | Adenylate cyclase inhibitor | 0.159 0.04 CID_5897 | ||
| 0.247 | 0.012 | 0.247 | GABA C receptor rho-2 antagonist | 0.162 0.059 CID_5897 | ||
| 0.261 | 0.032 | 0.261 | Focal adhesion kinase 2 inhibitor | 0.219 0.055 CID_5897 | ||
| 0.26 | 0.032 | 0.26 | I kappa B kinase epsilon inhibitor | 0.173 0.096 CID_5897 | ||
| 0.27 | 0.044 | 0.27 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.148 0.13 CID_5897 | ||
| 0.235 | 0.01 | 0.235 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.09 0.042 CID_5897 | ||
| 0.229 | 0.005 | 0.229 | Toll-Like receptor 3 antagonist | |||
| 0.226 | 0.005 | 0.226 | GABA C receptor rho-1 antagonist | 0.114 0.045 CID_5897 | ||
| 0.228 | 0.01 | 0.228 | Carbonic anhydrase VI inhibitor | 0.107 0.035 CID_5897 | ||
| 0.25 | 0.037 | 0.25 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.14 0.085 CID_5897 | ||
| 0.281 | 0.069 | 0.281 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.267 0.073 CID_5897 | ||
| 0.286 | 0.075 | 0.286 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.207 0.149 CID_5897 | ||
| 0.232 | 0.021 | 0.256 | Hexokinase inhibitor | 0.256 0.016 CID_5897 | CID_5897 | |
| 0.245 | 0.035 | 0.245 | Protein kinase C nu inhibitor | 0.123 0.089 CID_5897 | ||
| 0.26 | 0.055 | 0.26 | Psychostimulant | 0.137 0.128 CID_5897 | ||
| 0.289 | 0.086 | 0.289 | 12-Lipoxygenase inhibitor | 0.28 0.092 CID_5897 | ||
| 0.222 | 0.022 | 0.222 | Vascular endothelial growth factor 1 antagonist | 0.091 0.072 CID_5897 | ||
| 0.233 | 0.033 | 0.233 | Protein kinase (CK1) gamma 1 inhibitor | 0.139 0.079 CID_5897 | ||
| 0.255 | 0.058 | 0.255 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.203 | 0.009 | 0.203 | Check point kinase 1 inhibitor | 0.089 0.033 CID_5897 | ||
| 0.199 | 0.005 | 0.199 | Dopamine D5 antagonist | 0.038 0.034 CID_5897 | ||
| 0.24 | 0.047 | 0.24 | Non-steroidal antiinflammatory agent | 0.19 0.08 CID_5897 | ||
| 0.225 | 0.032 | 0.242 | 5 Hydroxytryptamine 3E antagonist | 0.242 0.02 CID_5897 | CID_5897 | |
| 0.223 | 0.03 | 0.223 | Interleukin 6 antagonist | |||
| 0.212 | 0.02 | 0.268 | Ferrochelatase inhibitor | 0.268 0.011 CID_5897 | CID_5897 | |
| 0.202 | 0.011 | 0.202 | Protein kinase C zeta inhibitor | 0.096 0.056 CID_5897 | ||
| 0.215 | 0.026 | 0.215 | Toll-Like receptor antagonist | 0.114 0.095 CID_5897 | ||
| 0.259 | 0.069 | 0.297 | Gastrin inhibitor | 0.297 0.035 CID_5897 | CID_5897 | |
| 0.198 | 0.009 | 0.198 | Nitric-oxide synthase inhibitor | 0.106 0.05 CID_5897 | ||
| 0.206 | 0.018 | 0.206 | Carbonic anhydrase XV inhibitor | 0.118 0.048 CID_5897 | ||
| 0.215 | 0.029 | 0.215 | Acetylcholinesterase inhibitor | |||
| 0.2 | 0.015 | 0.2 | 5 Hydroxytryptamine 3A agonist | 0.116 0.06 CID_5897 | ||
| 0.268 | 0.085 | 0.268 | Hypoxia-inducible factor 1 alpha inhibitor | 0.181 0.177 CID_5897 | ||
| 0.285 | 0.103 | 0.285 | Transcription factor NF kappa B inhibitor | 0.221 0.149 CID_5897 | ||
| 0.203 | 0.023 | 0.203 | Alpha 2b adrenoreceptor antagonist | 0.117 0.06 CID_5897 | ||
| 0.201 | 0.022 | 0.201 | Cathepsin H inhibitor | 0.156 0.042 CID_5897 | ||
| 0.209 | 0.031 | 0.443 | Alpha-N-acetylglucosaminidase inhibitor | 0.443 0.007 CID_5897 | CID_5897 | |
| 0.281 | 0.104 | 0.281 | Vasodilator, coronary | 0.217 0.167 CID_5897 | ||
| 0.181 | 0.005 | 0.181 | GABA aminotransferase inhibitor | 0.089 0.036 CID_5897 | ||
| 0.193 | 0.017 | 0.193 | Adenylate cyclase stimulant | 0.136 0.089 CID_5897 | ||
| 0.228 | 0.053 | 0.228 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.162 0.117 CID_5897 | ||
| 0.2 | 0.026 | 0.2 | Alkylator | 0.155 0.044 CID_5897 | ||
| 0.192 | 0.019 | 0.192 | Beta amyloid protein antagonist | |||
| 0.24 | 0.069 | 0.24 | Cyclic AMP phosphodiesterase inhibitor | 0.183 0.108 CID_5897 | ||
| 0.176 | 0.005 | 0.176 | Glutamate release inhibitor | |||
| 0.191 | 0.023 | 0.191 | Nav1.6 sodium channel blocker | 0.114 0.106 CID_5897 | ||
| 0.193 | 0.026 | 0.193 | CF transmembrane conductance regulator agonist | 0.172 0.044 CID_5897 | ||
| 0.208 | 0.042 | 0.208 | Succinate dehydrogenase inhibitor | 0.19 0.057 CID_5897 | ||
| 0.176 | 0.01 | 0.176 | I kappa B kinase inhibitor | 0.121 0.026 CID_5897 | ||
| 0.221 | 0.059 | 0.221 | Nitric-oxide synthase stimulant | 0.19 0.106 CID_5897 | ||
| 0.234 | 0.072 | 0.279 | Neuropeptide Y2 antagonist | 0.279 0.031 CID_5897 | CID_5897 | |
| 0.197 | 0.036 | 0.197 | Arachidonic acid antagonist | 0.152 0.086 CID_5897 | ||
| 0.174 | 0.016 | 0.174 | DNA repair enzyme inhibitor | 0.142 0.039 CID_5897 | ||
| 0.203 | 0.045 | 0.203 | Cholinergic | |||
| 0.211 | 0.054 | 0.211 | Histone acetyltransferase inhibitor | |||
| 0.189 | 0.035 | 0.189 | Anesthetic local | 0.128 0.062 CID_5897 | ||
| 0.192 | 0.039 | 0.192 | Tubulin antagonist | |||
| 0.163 | 0.01 | 0.163 | Acetylcholine release stimulant | 0.123 0.044 CID_5897 | ||
| 0.156 | 0.005 | 0.156 | Potassium channel (Ca-activated) blocker | 0.072 0.024 CID_5897 | ||
| 0.2 | 0.049 | 0.2 | Heat shock protein 90 alpha antagonist | 0.174 0.067 CID_5897 | ||
| 0.188 | 0.037 | 0.188 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.196 | 0.046 | 0.196 | Amylase inhibitor | |||
| 0.166 | 0.018 | 0.166 | Telomerase inhibitor | 0.14 0.022 CID_5897 | ||
| 0.154 | 0.006 | 0.154 | NMDA 2C receptor antagonist | 0.092 0.019 CID_5897 | ||
| 0.164 | 0.019 | 0.164 | Ca2+-transporting ATPase inhibitor | 0.143 0.061 CID_5897 | ||
| 0.189 | 0.044 | 0.189 | Cyclin-dependent kinase 8 inhibitor | 0.175 0.056 CID_5897 | ||
| 0.192 | 0.047 | 0.192 | Protein kinase (CK1) gamma inhibitor | |||
| 0.159 | 0.015 | 0.159 | NMDA 2 receptor antagonist | 0.077 0.046 CID_5897 | ||
| 0.187 | 0.044 | 0.187 | Catenin beta inhibitor | 0.149 0.109 CID_5897 | ||
| 0.166 | 0.023 | 0.166 | Protein kinase C gamma inhibitor | 0.114 0.058 CID_5897 | ||
| 0.161 | 0.018 | 0.161 | Phosphodiesterase 7B inhibitor | |||
| 0.146 | 0.005 | 0.146 | I kappa B kinase 2 inhibitor | 0.099 0.013 CID_5897 | ||
| 0.153 | 0.013 | 0.153 | Histamine N-methyltransferase inhibitor | 0.089 0.057 CID_5897 | ||
| 0.159 | 0.02 | 0.159 | Creatine kinase inhibitor | 0.112 0.048 CID_5897 | ||
| 0.146 | 0.007 | 0.146 | Alpha 2 adrenoreceptor agonist | 0.063 0.039 CID_5897 | ||
| 0.171 | 0.032 | 0.171 | Cystathionine beta-synthase inhibitor | |||
| 0.171 | 0.033 | 0.228 | Cyclooxygenase 3 inhibitor | 0.228 0.012 CID_5897 | CID_5897 | |
| 0.148 | 0.012 | 0.148 | Lanosterol 14 alpha demethylase inhibitor | 0.107 0.045 CID_5897 | ||
| 0.159 | 0.023 | 0.159 | Adenylate kinase inhibitor | 0.097 0.072 CID_5897 | ||
| 0.144 | 0.008 | 0.144 | Glycine receptor agonist | 0.079 0.04 CID_5897 | ||
| 0.171 | 0.038 | 0.171 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.115 0.074 CID_5897 | ||
| 0.17 | 0.038 | 0.17 | Abl kinase inhibitor | 0.114 0.074 CID_5897 | ||
| 0.151 | 0.018 | 0.151 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.09 0.043 CID_5897 | ||
| 0.143 | 0.011 | 0.143 | Interferon agonist | 0.082 0.048 CID_5897 | ||
| 0.159 | 0.027 | 0.19 | Papain-like protease (SARS coronavirus) inhibitor | 0.19 0.013 CID_5897 | CID_5897 | |
| 0.17 | 0.039 | 0.17 | Neuropeptide Y1 antagonist | 0.162 0.048 CID_5897 | ||
| 0.136 | 0.005 | 0.136 | Topoisomerase II beta inhibitor | 0.11 0.008 CID_5897 | ||
| 0.15 | 0.021 | 0.15 | DOPA decarboxylase inhibitor | 0.097 0.082 CID_5897 | ||
| 0.137 | 0.009 | 0.137 | 5 Hydroxytryptamine 5A antagonist | 0.066 0.036 CID_5897 | ||
| 0.145 | 0.016 | 0.145 | MAP-kinase-activated kinase inhibitor | |||
| 0.201 | 0.075 | 0.201 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.135 | 0.009 | 0.135 | Granulocyte macrophage colony stimulating factor agonist | 0.093 0.046 CID_5897 | ||
| 0.153 | 0.027 | 0.153 | Potassium channel (Ca-activated) activator | |||
| 0.168 | 0.042 | 0.168 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.143 | 0.018 | 0.143 | Inducible nitric-oxide synthase inhibitor | |||
| 0.166 | 0.043 | 0.166 | Topoisomerase II inhibitor | 0.096 0.09 CID_5897 | ||
| 0.128 | 0.005 | 0.128 | Potassium channel small-conductance Ca-activated blocker | 0.059 0.018 CID_5897 | ||
| 0.146 | 0.024 | 0.146 | Prolactin inhibitor | 0.122 0.037 CID_5897 | ||
| 0.199 | 0.077 | 0.199 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.148 0.122 CID_5897 | ||
| 0.174 | 0.052 | 0.174 | Heat shock protein 90 antagonist | 0.13 0.098 CID_5897 | ||
| 0.135 | 0.015 | 0.135 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.212 | 0.092 | 0.212 | Antiamyloidogenic | |||
| 0.138 | 0.018 | 0.138 | Alpha adrenoreceptor agonist | |||
| 0.176 | 0.056 | 0.176 | Diuretic | 0.157 0.071 CID_5897 | ||
| 0.166 | 0.047 | 0.166 | MAP kinase 3 inhibitor | 0.163 0.05 CID_5897 | ||
| 0.153 | 0.034 | 0.153 | MAP kinase kinase kinase inhibitor | 0.134 0.043 CID_5897 | ||
| 0.129 | 0.01 | 0.129 | D-Ala-D-Ala ligase inhibitor | 0.097 0.034 CID_5897 | ||
| 0.129 | 0.01 | 0.129 | 5 Hydroxytryptamine 5 antagonist | 0.058 0.04 CID_5897 | ||
| 0.245 | 0.127 | 0.305 | Angiogenesis inhibitor | 0.305 0.09 CID_5897 | CID_5897 | |
| 0.141 | 0.023 | 0.141 | Anabolic | 0.13 0.031 CID_5897 | ||
| 0.156 | 0.039 | 0.156 | MAO A inhibitor | 0.137 0.045 CID_5897 | ||
| 0.169 | 0.053 | 0.169 | Ribosomal protein S6 kinase inhibitor | |||
| 0.155 | 0.039 | 0.155 | 5 Hydroxytryptamine 2B antagonist | 0.095 0.089 CID_5897 | ||
| 0.149 | 0.033 | 0.149 | Alpha 2c adrenoreceptor antagonist | |||
| 0.123 | 0.007 | 0.123 | CD45 antagonist | 0.08 0.012 CID_5897 | ||
| 0.14 | 0.024 | 0.14 | Alpha 2a adrenoreceptor antagonist | |||
| 0.141 | 0.027 | 0.141 | NMDA receptor antagonist | 0.085 0.059 CID_5897 | ||
| 0.145 | 0.034 | 0.145 | Photosensitizer | 0.119 0.059 CID_5897 | ||
| 0.242 | 0.133 | 0.321 | Vasodilator, peripheral | 0.321 0.087 CID_5897 | CID_5897 | |
| 0.131 | 0.023 | 0.131 | NADH dehydrogenase inhibitor | |||
| 0.125 | 0.017 | 0.125 | Phenylalanine 4-hydroxylase inhibitor | 0.069 0.047 CID_5897 | ||
| 0.227 | 0.12 | 0.258 | Insulysin inhibitor | 0.258 0.089 CID_5897 | CID_5897 | |
| 0.17 | 0.063 | 0.17 | Neurotensin receptor agonist | 0.17 0.062 CID_5897 | ||
| 0.114 | 0.007 | 0.114 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.061 CID_5897 | ||
| 0.109 | 0.004 | 0.109 | Dopamine D5 agonist | 0.049 0.019 CID_5897 | ||
| 0.162 | 0.059 | 0.162 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.223 | 0.12 | 0.223 | Lipoxygenase inhibitor | 0.179 0.165 CID_5897 | ||
| 0.152 | 0.049 | 0.152 | TRKA antagonist | 0.096 0.095 CID_5897 | ||
| 0.117 | 0.015 | 0.117 | T cell inhibitor | 0.081 0.062 CID_5897 | ||
| 0.142 | 0.04 | 0.142 | Interleukin 8 antagonist | |||
| 0.12 | 0.018 | 0.158 | Glycine receptor antagonist | 0.158 0.006 CID_5897 | CID_5897 | |
| 0.211 | 0.11 | 0.211 | Spasmolytic | |||
| 0.137 | 0.038 | 0.137 | Nav1.1 sodium channel blocker | |||
| 0.14 | 0.042 | 0.14 | GABA receptor agonist | 0.099 0.078 CID_5897 | ||
| 0.158 | 0.061 | 0.158 | Activin receptor-like kinase 2 inhibitor | |||
| 0.113 | 0.015 | 0.113 | Alcohol oxidase inhibitor | 0.096 0.019 CID_5897 | ||
| 0.124 | 0.027 | 0.124 | Porphobilinogen synthase inhibitor | 0.083 0.045 CID_5897 | ||
| 0.21 | 0.114 | 0.23 | Immunostimulant | 0.23 0.105 CID_5897 | CID_5897 | |
| 0.15 | 0.054 | 0.15 | NADPH oxidase inhibitor | 0.123 0.079 CID_5897 | ||
| 0.104 | 0.009 | 0.104 | Glutamate (mGluR6) antagonist | 0.073 0.034 CID_5897 | ||
| 0.12 | 0.025 | 0.12 | Histidine decarboxylase inhibitor | |||
| 0.128 | 0.034 | 0.128 | Alpha 2 adrenoreceptor antagonist | |||
| 0.136 | 0.042 | 0.151 | TRPA1 agonist | 0.151 0.03 CID_5897 | CID_5897 | |
| 0.131 | 0.037 | 0.15 | UDP-glucose 4-epimerase inhibitor | 0.15 0.029 CID_5897 | CID_5897 | |
| 0.107 | 0.014 | 0.107 | Purinergic P2X1 antagonist | |||
| 0.097 | 0.004 | 0.097 | Adenylate cyclase 1 inhibitor | 0.055 0.021 CID_5897 | ||
| 0.133 | 0.041 | 0.133 | Butyrylcholinesterase inhibitor | |||
| 0.149 | 0.058 | 0.149 | Nav1.2 sodium channel blocker | 0.129 0.073 CID_5897 | ||
| 0.158 | 0.067 | 0.158 | Acetylcholine M1 receptor antagonist | |||
| 0.165 | 0.074 | 0.165 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.124 | 0.034 | 0.124 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.165 | 0.076 | 0.279 | Death-associated protein kinase 2 inhibitor | 0.279 0.009 CID_5897 | CID_5897 | |
| 0.172 | 0.084 | 0.172 | TRKC antagonist | |||
| 0.119 | 0.031 | 0.154 | Glutamate (mGluR7) agonist | 0.154 0.01 CID_5897 | CID_5897 | |
| 0.121 | 0.034 | 0.121 | MAP kinase kinase 1 inhibitor | |||
| 0.167 | 0.08 | 0.167 | Tumour necrosis factor antagonist | |||
| 0.099 | 0.013 | 0.099 | NMDA 2A receptor antagonist | |||
| 0.109 | 0.024 | 0.109 | Nicotinic alpha4beta2 receptor antagonist | 0.069 0.063 CID_5897 | ||
| 0.121 | 0.036 | 0.121 | Electrolyte absorption antagonist | 0.107 0.048 CID_5897 | ||
| 0.136 | 0.051 | 0.136 | Interleukin 1b antagonist | 0.11 0.071 CID_5897 | ||
| 0.176 | 0.091 | 0.176 | Amyloid beta aggregation inhibitor | |||
| 0.095 | 0.01 | 0.095 | Glutamate (mGluR group III) agonist | 0.057 0.02 CID_5897 | ||
| 0.151 | 0.068 | 0.151 | Protein kinase stimulant | 0.127 0.086 CID_5897 | ||
| 0.115 | 0.032 | 0.115 | Topoisomerase II alpha inhibitor | 0.098 0.041 CID_5897 | ||
| 0.096 | 0.013 | 0.096 | Glutamate (mGluR7) antagonist | 0.067 0.048 CID_5897 | ||
| 0.109 | 0.027 | 0.109 | Histamine H2 receptor antagonist | 0.076 0.074 CID_5897 | ||
| 0.108 | 0.026 | 0.108 | Keratolytic | 0.098 0.032 CID_5897 | ||
| 0.097 | 0.017 | 0.097 | 5 Hydroxytryptamine 3 agonist | |||
| 0.087 | 0.007 | 0.087 | Prolactin release inhibitor | 0.059 0.055 CID_5897 | ||
| 0.093 | 0.014 | 0.093 | AMPA receptor antagonist | |||
| 0.105 | 0.025 | 0.105 | Dopamine agonist | |||
| 0.086 | 0.007 | 0.086 | Sodium/calcium exchanger inhibitor | |||
| 0.145 | 0.067 | 0.145 | Tyrosine-protein kinase receptor antagonist | |||
| 0.109 | 0.031 | 0.109 | Glutamate receptor agonist | 0.071 0.062 CID_5897 | ||
| 0.129 | 0.051 | 0.129 | Topoisomerase I inhibitor | |||
| 0.096 | 0.018 | 0.121 | NMDA receptor glycine site agonist | 0.121 0.009 CID_5897 | CID_5897 | |
| 0.082 | 0.005 | 0.082 | Alpha 1d adrenoreceptor agonist | 0.053 0.014 CID_5897 | ||
| 0.192 | 0.114 | 0.192 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.114 | 0.036 | 0.114 | Triose-phosphate isomerase inhibitor | 0.092 0.056 CID_5897 | ||
| 0.083 | 0.006 | 0.083 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.027 CID_5897 | ||
| 0.176 | 0.099 | 0.176 | Insulin sensitizer | 0.166 0.112 CID_5897 | ||
| 0.097 | 0.02 | 0.097 | Secretase beta inhibitor | 0.093 0.022 CID_5897 | ||
| 0.161 | 0.084 | 0.201 | ATPase inhibitor | 0.201 0.036 CID_5897 | CID_5897 | |
| 0.117 | 0.041 | 0.158 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.158 0.024 CID_5897 | CID_5897 | |
| 0.251 | 0.176 | 0.251 | Antibacterial | |||
| 0.104 | 0.029 | 0.104 | mTOR complex 2 inhibitor | |||
| 0.1 | 0.025 | 0.1 | Dopamine D1 antagonist | |||
| 0.094 | 0.02 | 0.094 | Biliverdin reductase inhibitor | 0.056 0.045 CID_5897 | ||
| 0.092 | 0.018 | 0.092 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.132 | 0.058 | 0.132 | 5 Hydroxytryptamine antagonist | |||
| 0.154 | 0.08 | 0.154 | Polo-like kinase-3 inhibitor | |||
| 0.093 | 0.02 | 0.093 | MAP kinase kinase 7 inhibitor | 0.078 0.053 CID_5897 | ||
| 0.121 | 0.048 | 0.121 | Check point kinase 2 inhibitor | |||
| 0.086 | 0.014 | 0.086 | Potassium channel intermediate-conductance Ca-activated blocker | 0.06 0.042 CID_5897 | ||
| 0.079 | 0.006 | 0.079 | Immunoglobulin Fc receptor antagonist | 0.065 0.017 CID_5897 | ||
| 0.077 | 0.004 | 0.077 | Phenylethanolamine N methyltransferase inhibitor | 0.049 0.015 CID_5897 | ||
| 0.103 | 0.032 | 0.103 | Myeloperoxidase inhibitor | |||
| 0.094 | 0.023 | 0.094 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.093 | 0.023 | 0.093 | Aromatase inhibitor | |||
| 0.094 | 0.024 | 0.094 | Beta tubulin antagonist | |||
| 0.166 | 0.096 | 0.166 | MAP kinase kinase 5 inhibitor | |||
| 0.141 | 0.072 | 0.141 | Heat shock protein 70 antagonist | 0.14 0.076 CID_5897 | ||
| 0.104 | 0.035 | 0.104 | Acetylcholine nicotinic agonist | 0.094 0.042 CID_5897 | ||
| 0.142 | 0.073 | 0.143 | Vascular endothelial growth factor 3 antagonist | 0.143 0.071 CID_5897 | CID_5897 | |
| 0.097 | 0.029 | 0.097 | Estrogen-related receptor beta agonist | 0.079 0.069 CID_5897 | ||
| 0.078 | 0.01 | 0.078 | Kainate receptor antagonist | |||
| 0.076 | 0.008 | 0.076 | Retinoid X alpha receptor agonist | |||
| 0.072 | 0.004 | 0.072 | ATM kinase inhibitor | 0.059 0.005 CID_5897 | ||
| 0.072 | 0.005 | 0.072 | Nerve growth factor antagonist | 0.057 0.011 CID_5897 | ||
| 0.134 | 0.067 | 0.134 | Cyclooxygenase 1 inhibitor | |||
| 0.079 | 0.013 | 0.079 | Lysine-specific demethylase 1A inhibitor | |||
| 0.178 | 0.112 | 0.178 | Dyrk kinase inhibitor | |||
| 0.129 | 0.064 | 0.151 | Nav1.3 sodium channel blocker | 0.151 0.047 CID_5897 | CID_5897 | |
| 0.098 | 0.033 | 0.098 | Phosphofructokinase-1 inhibitor | |||
| 0.143 | 0.078 | 0.143 | MAP kinase kinase 4 inhibitor | |||
| 0.075 | 0.01 | 0.075 | Histamine H4 receptor antagonist | |||
| 0.113 | 0.048 | 0.113 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.102 0.055 CID_5897 | ||
| 0.118 | 0.054 | 0.118 | Granulocyte macrophage colony stimulating factor antagonist | 0.092 0.081 CID_5897 | ||
| 0.074 | 0.01 | 0.074 | Thymidylate synthase inhibitor | |||
| 0.105 | 0.041 | 0.105 | Pim-3 kinase inhibitor | |||
| 0.118 | 0.054 | 0.118 | Aminopeptidase B inhibitor | 0.087 0.075 CID_5897 | ||
| 0.086 | 0.023 | 0.086 | 5 Hydroxytryptamine 2A agonist | |||
| 0.121 | 0.058 | 0.121 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.131 | 0.069 | 0.131 | MAO inhibitor | 0.105 0.085 CID_5897 | ||
| 0.077 | 0.015 | 0.077 | Aconitate hydratase inhibitor | |||
| 0.076 | 0.014 | 0.076 | Epithelial sodium channel blocker | |||
| 0.099 | 0.038 | 0.099 | Carbonic anhydrase XIII inhibitor | |||
| 0.086 | 0.025 | 0.105 | NMDA receptor agonist | 0.105 0.017 CID_5897 | CID_5897 | |
| 0.081 | 0.02 | 0.081 | Heat shock protein 90 beta antagonist | |||
| 0.086 | 0.026 | 0.086 | Phospholipase D inhibitor | 0.068 0.059 CID_5897 | ||
| 0.156 | 0.096 | 0.156 | CDC-like kinase 4 inhibitor | |||
| 0.106 | 0.046 | 0.106 | Alcohol dehydrogenase inhibitor | |||
| 0.08 | 0.02 | 0.08 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.14 | 0.081 | 0.14 | Hemostatic | 0.135 0.089 CID_5897 | ||
| 0.086 | 0.026 | 0.086 | Histone deacetylase inhibitor | 0.085 0.027 CID_5897 | ||
| 0.079 | 0.02 | 0.097 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.097 0.011 CID_5897 | CID_5897 | |
| 0.082 | 0.023 | 0.084 | Androgen agonist | 0.084 0.022 CID_5897 | CID_5897 | |
| 0.096 | 0.038 | 0.096 | CYP2A6 inhibitor | |||
| 0.209 | 0.151 | 0.209 | Prostaglandin dehydrogenase inhibitor | |||
| 0.105 | 0.047 | 0.116 | Potassium channel (Voltage-sensitive) activator | 0.116 0.036 CID_5897 | CID_5897 | |
| 0.087 | 0.03 | 0.087 | GABA B receptor agonist | 0.078 0.046 CID_5897 | ||
| 0.092 | 0.035 | 0.092 | Glutamate decarboxylase inhibitor | |||
| 0.081 | 0.024 | 0.081 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.081 | 0.025 | 0.081 | Argininosuccinate synthase inhibitor | |||
| 0.066 | 0.01 | 0.066 | GABA B receptor antagonist | |||
| 0.065 | 0.01 | 0.065 | Geranyltranstransferase inhibitor | 0.04 0.038 CID_5897 | ||
| 0.118 | 0.063 | 0.118 | Microtubule formation inhibitor | 0.1 0.091 CID_5897 | ||
| 0.08 | 0.025 | 0.08 | Exportin-1 inhibitor | |||
| 0.071 | 0.016 | 0.092 | Dihydroorotate oxidase inhibitor | 0.092 0.006 CID_5897 | CID_5897 | |
| 0.107 | 0.052 | 0.107 | Estrogen receptor beta antagonist | |||
| 0.076 | 0.021 | 0.076 | Alpha tubulin antagonist | |||
| 0.061 | 0.007 | 0.061 | Glutamate (mGluR8) agonist | 0.039 0.025 CID_5897 | ||
| 0.074 | 0.019 | 0.074 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.058 0.031 CID_5897 | ||
| 0.136 | 0.082 | 0.159 | Pregnane X receptor agonist | 0.159 0.039 CID_5897 | CID_5897 | |
| 0.113 | 0.059 | 0.159 | Falcipain 3 inhibitor | 0.159 0.033 CID_5897 | CID_5897 | |
| 0.09 | 0.037 | 0.09 | Glutamate dehydrogenase inhibitor | 0.065 0.064 CID_5897 | ||
| 0.114 | 0.061 | 0.114 | DNA intercalator | |||
| 0.067 | 0.015 | 0.067 | NMDA receptor subunit 3A antagonist | |||
| 0.06 | 0.007 | 0.06 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.075 | 0.023 | 0.075 | Cyclin D1 inhibitor | 0.073 0.025 CID_5897 | ||
| 0.07 | 0.018 | 0.07 | Ryanodine receptor antagonist | |||
| 0.151 | 0.099 | 0.232 | 3C-like protease (Human coronavirus) inhibitor | 0.232 0.036 CID_5897 | CID_5897 | |
| 0.064 | 0.012 | 0.064 | Retinoid X receptor agonist | |||
| 0.06 | 0.01 | 0.06 | Dihydrofolate reductase inhibitor | |||
| 0.137 | 0.086 | 0.177 | Sphingosine 1-phosphate receptor 5 antagonist | 0.177 0.026 CID_5897 | CID_5897 | |
| 0.075 | 0.025 | 0.075 | Carbonic anhydrase VB inhibitor | |||
| 0.122 | 0.072 | 0.122 | Glutamate receptor antagonist | |||
| 0.073 | 0.024 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | 0.068 0.031 CID_5897 | ||
| 0.057 | 0.008 | 0.057 | Integrin alpha2 antagonist | |||
| 0.14 | 0.092 | 0.14 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.207 | 0.159 | 0.207 | Cholesterol antagonist | |||
| 0.058 | 0.01 | 0.058 | Histamine H1 receptor agonist | 0.044 0.03 CID_5897 | ||
| 0.076 | 0.028 | 0.076 | Interferon inducer | |||
| 0.104 | 0.056 | 0.104 | MAP kinase 8 inhibitor | |||
| 0.057 | 0.009 | 0.057 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.075 | 0.028 | 0.091 | Beta 3 adrenoreceptor antagonist | 0.091 0.018 CID_5897 | CID_5897 | |
| 0.059 | 0.012 | 0.059 | Dihydropteroate synthase inhibitor | 0.039 0.028 CID_5897 | ||
| 0.072 | 0.025 | 0.072 | Calcium channel P-type blocker | |||
| 0.064 | 0.017 | 0.064 | NMDA receptor subunit 3B antagonist | |||
| 0.106 | 0.06 | 0.117 | Urease inhibitor | 0.117 0.048 CID_5897 | CID_5897 | |
| 0.07 | 0.025 | 0.07 | NMDA 2B receptor antagonist | |||
| 0.072 | 0.027 | 0.072 | Transcription factor RelA inhibitor | |||
| 0.102 | 0.057 | 0.102 | Sphingomyelinase inhibitor | 0.093 0.068 CID_5897 | ||
| 0.056 | 0.012 | 0.056 | AMPA 4 receptor antagonist | |||
| 0.098 | 0.055 | 0.098 | Phosphodiesterase 6D inhibitor | 0.094 0.066 CID_5897 | ||
| 0.055 | 0.012 | 0.055 | Acid-sensing ion channel blocker | |||
| 0.058 | 0.016 | 0.058 | AICAR transformylase inhibitor | 0.046 0.027 CID_5897 | ||
| 0.097 | 0.055 | 0.097 | Protein kinase C delta inhibitor | |||
| 0.069 | 0.027 | 0.069 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.078 | 0.038 | 0.078 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.063 | 0.023 | 0.063 | Carbonic anhydrase XIV inhibitor | 0.048 0.035 CID_5897 | ||
| 0.113 | 0.073 | 0.113 | Vascular endothelial growth factor antagonist | |||
| 0.067 | 0.028 | 0.067 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.092 | 0.053 | 0.095 | Bromodomain-containing protein 2 inhibitor | 0.095 0.046 CID_5897 | CID_5897 | |
| 0.061 | 0.023 | 0.061 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.096 | 0.058 | 0.096 | Bile acid receptor antagonist | |||
| 0.057 | 0.019 | 0.057 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.059 | 0.02 | 0.059 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.073 | 0.035 | 0.088 | 5 Hydroxytryptamine 1D antagonist | 0.088 0.027 CID_5897 | CID_5897 | |
| 0.116 | 0.078 | 0.116 | MAP kinase kinase inhibitor | |||
| 0.112 | 0.075 | 0.121 | Transcription factor STAT6 inhibitor | 0.121 0.058 CID_5897 | CID_5897 | |
| 0.085 | 0.048 | 0.098 | CC chemokine 5 receptor agonist | 0.098 0.025 CID_5897 | CID_5897 | |
| 0.206 | 0.169 | 0.223 | Antithrombotic | 0.223 0.151 CID_5897 | CID_5897 | |
| 0.079 | 0.043 | 0.079 | Aminopeptidase I inhibitor | 0.066 0.058 CID_5897 | ||
| 0.087 | 0.052 | 0.087 | GABA A receptor agonist | 0.077 0.07 CID_5897 | ||
| 0.076 | 0.04 | 0.076 | Carbonic anhydrase VA inhibitor | 0.072 0.044 CID_5897 | ||
| 0.042 | 0.007 | 0.042 | 5 Hydroxytryptamine 6 agonist | |||
| 0.043 | 0.008 | 0.043 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.074 | 0.04 | 0.074 | Carbonic anhydrase V inhibitor | 0.067 0.045 CID_5897 | ||
| 0.042 | 0.008 | 0.042 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.02 0.018 CID_5897 | ||
| 0.067 | 0.034 | 0.067 | Phosphodiesterase 1C inhibitor | 0.058 0.053 CID_5897 | ||
| 0.084 | 0.05 | 0.084 | Acetylcholine nicotinic antagonist | |||
| 0.074 | 0.041 | 0.074 | Neuronal nicotinic receptor antagonist | |||
| 0.037 | 0.005 | 0.037 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.037 | 0.004 | 0.037 | Alpha 2a adrenoreceptor agonist | |||
| 0.037 | 0.004 | 0.037 | Alpha 2c adrenoreceptor agonist | 0.026 0.006 CID_5897 | ||
| 0.043 | 0.011 | 0.043 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.051 | 0.019 | 0.051 | Glutamate (mGluR group III) antagonist | |||
| 0.059 | 0.027 | 0.059 | 5 Hydroxytryptamine 2 agonist | |||
| 0.055 | 0.024 | 0.055 | Dopamine D2 agonist | |||
| 0.109 | 0.078 | 0.109 | Estrogen antagonist | |||
| 0.046 | 0.016 | 0.046 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.068 | 0.038 | 0.068 | Phosphodiesterase VII inhibitor | |||
| 0.041 | 0.013 | 0.041 | AMPA 3 receptor antagonist | |||
| 0.083 | 0.054 | 0.083 | Adrenaline agonist | |||
| 0.119 | 0.09 | 0.119 | Interleukin 1 antagonist | |||
| 0.079 | 0.051 | 0.079 | Estrogen receptor alpha antagonist | |||
| 0.096 | 0.068 | 0.096 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.138 | 0.11 | 0.138 | Antipruritic | |||
| 0.069 | 0.042 | 0.069 | Potassium channel (ATP-sensitive) blocker | 0.061 0.059 CID_5897 | ||
| 0.032 | 0.004 | 0.032 | NMDA receptor phencyclidine site antagonist | |||
| 0.071 | 0.045 | 0.071 | Protein kinase C beta inhibitor | |||
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR4) antagonist | |||
| 0.035 | 0.008 | 0.035 | Integrin alpha2beta1 antagonist | |||
| 0.044 | 0.018 | 0.047 | Potassium channel Kv1.1 blocker | 0.047 0.015 CID_5897 | CID_5897 | |
| 0.049 | 0.023 | 0.049 | Histamine H2 receptor agonist | |||
| 0.155 | 0.13 | 0.201 | Growth factor agonist | 0.201 0.062 CID_5897 | CID_5897 | |
| 0.051 | 0.026 | 0.051 | Cytokine production stimulant | |||
| 0.07 | 0.044 | 0.07 | Protein kinase C alpha inhibitor | |||
| 0.039 | 0.014 | 0.051 | Melatonin receptor 1A agonist | 0.051 0.007 CID_5897 | CID_5897 | |
| 0.088 | 0.063 | 0.121 | Potassium channel activator | 0.121 0.032 CID_5897 | CID_5897 | |
| 0.132 | 0.107 | 0.132 | CDC-like kinase 2 inhibitor | |||
| 0.097 | 0.073 | 0.118 | Mediator release inhibitor | 0.118 0.049 CID_5897 | CID_5897 | |
| 0.044 | 0.019 | 0.044 | 5 Hydroxytryptamine 2B agonist | |||
| 0.046 | 0.022 | 0.046 | Histone deacetylase class I inhibitor | 0.042 0.024 CID_5897 | ||
| 0.046 | 0.021 | 0.046 | Heme oxygenase inhibitor | |||
| 0.054 | 0.03 | 0.057 | Lysophosphatidic acid 3 receptor antagonist | 0.057 0.026 CID_5897 | CID_5897 | |
| 0.032 | 0.008 | 0.032 | Glutamate (mGluR1) agonist | 0.025 0.015 CID_5897 | ||
| 0.14 | 0.116 | 0.14 | DNA methyltransferase I inhibitor | 0.134 0.124 CID_5897 | ||
| 0.04 | 0.016 | 0.04 | Glutamate (mGluR4) agonist | |||
| 0.036 | 0.013 | 0.036 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.047 | 0.024 | 0.047 | Guanylate cyclase inhibitor | |||
| 0.052 | 0.029 | 0.052 | Phosphorylase inhibitor | |||
| 0.097 | 0.074 | 0.097 | Vascular endothelial growth factor 2 antagonist | |||
| 0.086 | 0.064 | 0.086 | Phosphodiesterase I inhibitor | |||
| 0.044 | 0.021 | 0.044 | GABA uptake inhibitor | |||
| 0.048 | 0.026 | 0.055 | Carbonic anhydrase IV inhibitor | 0.055 0.022 CID_5897 | CID_5897 | |
| 0.083 | 0.062 | 0.083 | Acetylcholine agonist | |||
| 0.07 | 0.049 | 0.07 | 5 Hydroxytryptamine 1F antagonist | 0.064 0.055 CID_5897 | ||
| 0.08 | 0.059 | 0.08 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.059 | 0.038 | 0.059 | Alpha 1 adrenoreceptor agonist | |||
| 0.033 | 0.012 | 0.033 | Dopamine autoreceptor agonist | |||
| 0.073 | 0.053 | 0.073 | Rho-associated kinase I inhibitor | 0.067 0.061 CID_5897 | ||
| 0.037 | 0.017 | 0.037 | Potassium channel small-conductance Ca-activated activator | |||
| 0.03 | 0.01 | 0.03 | Adenosine kinase inhibitor | |||
| 0.095 | 0.075 | 0.099 | Expectorant | 0.099 0.07 CID_5897 | CID_5897 | |
| 0.036 | 0.017 | 0.036 | Acetylcholine M4 receptor agonist | |||
| 0.055 | 0.037 | 0.055 | GABA receptor antagonist | |||
| 0.113 | 0.095 | 0.113 | Alkaline phosphatase inhibitor | |||
| 0.098 | 0.08 | 0.098 | Polo-like kinase-4 inhibitor | |||
| 0.062 | 0.045 | 0.062 | Carbonic anhydrase inhibitor | 0.062 0.045 CID_5897 | ||
| 0.04 | 0.022 | 0.04 | Kainate receptor 2 antagonist | |||
| 0.049 | 0.032 | 0.049 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.149 | 0.132 | 0.149 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.031 | 0.014 | 0.031 | Estrogen-related receptor gamma antagonist | |||
| 0.053 | 0.037 | 0.053 | GABA A receptor antagonist | |||
| 0.121 | 0.105 | 0.121 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.036 | 0.02 | 0.036 | Adenosine uptake inhibitor | |||
| 0.042 | 0.026 | 0.042 | Kainate receptor agonist | |||
| 0.195 | 0.179 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.052 | 0.036 | 0.052 | Phosphodiesterase 7A inhibitor | |||
| 0.048 | 0.032 | 0.056 | Benzodiazepine antagonist | 0.056 0.017 CID_5897 | CID_5897 | |
| 0.028 | 0.012 | 0.028 | Complement factor 1s inhibitor | |||
| 0.055 | 0.039 | 0.055 | Sphingosine kinase 2 inhibitor | |||
| 0.105 | 0.09 | 0.105 | Aldehyde dehydrogenase inhibitor | |||
| 0.042 | 0.027 | 0.042 | Thymidine kinase inhibitor | |||
| 0.048 | 0.033 | 0.048 | Aldosterone antagonist | 0.046 0.036 CID_5897 | ||
| 0.129 | 0.114 | 0.129 | Interferon gamma antagonist | |||
| 0.038 | 0.023 | 0.038 | Glutamate (mGluR3) antagonist | |||
| 0.031 | 0.016 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.038 | 0.023 | 0.041 | Progesterone antagonist | 0.041 0.022 CID_5897 | CID_5897 | |
| 0.03 | 0.015 | 0.03 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.109 | 0.094 | 0.109 | Lck kinase inhibitor | |||
| 0.053 | 0.039 | 0.064 | Nicotinic alpha7 receptor agonist | 0.064 0.028 CID_5897 | CID_5897 | |
| 0.055 | 0.041 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.046 | 0.032 | 0.063 | Purinergic P2X4 antagonist | 0.063 0.013 CID_5897 | CID_5897 | |
| 0.087 | 0.074 | 0.087 | 5-Lipoxygenase inhibitor | |||
| 0.024 | 0.011 | 0.024 | Imidazoline I1 receptor antagonist | 0.02 0.015 CID_5897 | ||
| 0.094 | 0.081 | 0.094 | Toll-Like receptor 4 antagonist | |||
| 0.079 | 0.066 | 0.116 | Androgen antagonist | 0.116 0.036 CID_5897 | CID_5897 | |
| 0.052 | 0.04 | 0.052 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.052 | 0.04 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | 0.056 0.031 CID_5897 | CID_5897 | |
| 0.138 | 0.126 | 0.138 | Clk dual-specificity kinase inhibitor | |||
| 0.04 | 0.03 | 0.04 | Plasmepsin II inhibitor | |||
| 0.067 | 0.056 | 0.067 | Benzodiazepine agonist | |||
| 0.037 | 0.027 | 0.037 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.07 | 0.06 | 0.07 | Na+ K+ transporting ATPase inhibitor | |||
| 0.069 | 0.059 | 0.069 | Acetylcholine M4 receptor antagonist | |||
| 0.052 | 0.042 | 0.052 | Carbonic anhydrase II inhibitor | 0.052 0.042 CID_5897 | ||
| 0.084 | 0.074 | 0.084 | Thioredoxin inhibitor | |||
| 0.089 | 0.079 | 0.089 | Insulin receptor antagonist | |||
| 0.075 | 0.066 | 0.116 | Neuropeptide Y antagonist | 0.116 0.031 CID_5897 | CID_5897 | |
| 0.029 | 0.02 | 0.029 | MAP3K8 inhibitor | |||
| 0.055 | 0.046 | 0.055 | Botulinum neurotoxin type A inhibitor | 0.053 0.05 CID_5897 | ||
| 0.037 | 0.028 | 0.037 | Retinoid X receptor antagonist | |||
| 0.068 | 0.06 | 0.07 | Protein kinase B gamma inhibitor | 0.07 0.057 CID_5897 | CID_5897 | |
| 0.076 | 0.067 | 0.076 | Calcium antagonist | |||
| 0.051 | 0.042 | 0.051 | Alpha-mannosidase inhibitor | |||
| 0.137 | 0.13 | 0.137 | DNA methylase inhibitor | |||
| 0.101 | 0.093 | 0.101 | Calcium channel N-type blocker | |||
| 0.034 | 0.027 | 0.034 | Opioid delta receptor agonist | |||
| 0.011 | 0.003 | 0.011 | DNA topoisomerase III inhibitor | 0.008 0.004 CID_5897 | ||
| 0.035 | 0.028 | 0.035 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.033 | 0.026 | 0.033 | Retinoid X alpha receptor antagonist | |||
| 0.049 | 0.042 | 0.049 | Histamine agonist | |||
| 0.047 | 0.04 | 0.047 | Dopamine D4 agonist | |||
| 0.038 | 0.032 | 0.038 | Glutamate (mGluR1a) antagonist | |||
| 0.034 | 0.027 | 0.034 | Arginase inhibitor | |||
| 0.037 | 0.031 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.026 | 0.02 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.019 | 0.013 | 0.019 | Antibiotic Anthracycline-like | |||
| 0.031 | 0.026 | 0.031 | Histone deacetylase 2 inhibitor | |||
| 0.026 | 0.02 | 0.026 | Lysine carboxypeptidase inhibitor | |||
| 0.104 | 0.099 | 0.104 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.049 | 0.044 | 0.053 | Carbonic anhydrase I inhibitor | 0.053 0.041 CID_5897 | CID_5897 | |
| 0.032 | 0.027 | 0.032 | Fumarate hydratase inhibitor | |||
| 0.047 | 0.042 | 0.047 | Ornithine carbamoyltransferase inhibitor | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.03 | 0.025 | 0.03 | ATP citrate lysase inhibitor | |||
| 0.055 | 0.05 | 0.055 | Glutamate (mGluR) agonist | |||
| 0.072 | 0.068 | 0.072 | Phosphodiesterase 3A inhibitor | |||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.027 | 0.022 | 0.027 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.027 | 0.023 | 0.027 | CDK4/cyclin D3 inhibitor | |||
| 0.046 | 0.041 | 0.046 | Dopamine beta hydroxylase inhibitor | |||
| 0.02 | 0.016 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.022 | 0.018 | 0.022 | Histone deacetylase 1 inhibitor | |||
| 0.054 | 0.051 | 0.054 | Acetylcholine M5 receptor antagonist | |||
| 0.031 | 0.028 | 0.031 | ATR kinase inhibitor | |||
| 0.02 | 0.017 | 0.021 | Factor XIII inhibitor | 0.021 0.013 CID_5897 | CID_5897 | |
| 0.018 | 0.015 | 0.018 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.049 | 0.047 | 0.054 | Nicotinic neuronal receptor agonist | 0.054 0.041 CID_5897 | CID_5897 | |
| 0.034 | 0.032 | 0.034 | Factor VIIa inhibitor | |||
| 0.047 | 0.045 | 0.047 | Carbonic anhydrase IX inhibitor | |||
| 0.04 | 0.039 | 0.074 | Dihydroorotase inhibitor | 0.074 0.01 CID_5897 | CID_5897 | |
| 0.031 | 0.03 | 0.031 | Phosphoglycerate kinase inhibitor | |||
| 0.014 | 0.013 | 0.014 | Purinergic P2Y1 agonist | |||
| 0.076 | 0.075 | 0.076 | Alpha adrenoreceptor antagonist | |||
| 0.03 | 0.029 | 0.03 | Glutamate (mGluR3) agonist | |||
| 0.031 | 0.03 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.075 | 0.074 | 0.075 | Caspase 7 inhibitor | |||
| 0.119 | 0.119 | 0.122 | Thiol protease inhibitor | 0.122 0.112 CID_5897 | CID_5897 | |
| 0.032 | 0.032 | 0.037 | Inosine monophosphate dehydrogenase inhibitor | 0.037 0.025 CID_5897 | CID_5897 | |
| 0.058 | 0.059 | 0.065 | Beta adrenoreceptor antagonist | 0.065 0.046 CID_5897 | CID_5897 | |
| 0.068 | 0.069 | 0.073 | Potassium channel (Tandem pore domain) blocker | 0.073 0.055 CID_5897 | CID_5897 | |
| 0.031 | 0.034 | 0.043 | Potassium channel KCNQ activator | 0.043 0.021 CID_5897 | CID_5897 | |
| 0.031 | 0.034 | 0.043 | Delayed rectifier potassium channel activator | 0.043 0.021 CID_5897 | CID_5897 | |
| 0.025 | 0.028 | 0.029 | Glucosylceramidase stimulant | 0.029 0.015 CID_5897 | CID_5897 | |
| 0.09 | 0.093 | 0.108 | Mucolytic | 0.108 0.067 CID_5897 | CID_5897 | |
| 0.061 | 0.064 | 0.151 | Catalase inhibitor | 0.151 0.026 CID_5897 | CID_5897 | |
| 0.03 | 0.034 | 0.051 | Histone deacetylase 7 inhibitor | 0.051 0.018 CID_5897 | CID_5897 | |
| 0.014 | 0.02 | 0.017 | Nicotinic acid receptor 1 antagonist | 0.017 0.013 CID_5897 | CID_5897 | |
| 0.047 | 0.054 | 0.064 | Heparanase inhibitor | 0.064 0.017 CID_5897 | CID_5897 | |
| 0.031 | 0.038 | 0.04 | Diamine oxidase inhibitor | 0.04 0.023 CID_5897 | CID_5897 | |
| 0.055 | 0.063 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.044 CID_5897 | CID_5897 | |
| 0.099 | 0.107 | 0.141 | Toll-Like receptor 2 antagonist | 0.141 0.059 CID_5897 | CID_5897 | |
| 0.033 | 0.042 | 0.042 | Histone deacetylase 9 inhibitor | 0.042 0.023 CID_5897 | CID_5897 | |
| 0.017 | 0.027 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.026 0.007 CID_5897 | CID_5897 | |
| 0.02 | 0.031 | 0.031 | Cyclin E2 inhibitor | 0.031 0.018 CID_5897 | CID_5897 | |
| 0.014 | 0.025 | 0.025 | Apolipoprotein B inhibitor | 0.025 0.01 CID_5897 | CID_5897 | |
| 0.103 | 0.114 | 0.137 | Sphingosine 1-phosphate receptor 4 antagonist | 0.137 0.047 CID_5897 | CID_5897 | |
| 0.017 | 0.028 | 0.023 | NMDA receptor glycine site antagonist | 0.023 0.018 CID_5897 | CID_5897 | |
| 0.009 | 0.021 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | 0.015 0.007 CID_5897 | CID_5897 | |
| 0.111 | 0.123 | 0.147 | Sphingosine 1-phosphate receptor 2 antagonist | 0.147 0.045 CID_5897 | CID_5897 | |
| 0.008 | 0.021 | 0.017 | Carbonic anhydrase XI inhibitor | 0.017 0.005 CID_5897 | CID_5897 | |
| 0.009 | 0.023 | 0.049 | Melatonin receptor 1A antagonist | 0.049 0.004 CID_5897 | CID_5897 | |
| 0.035 | 0.048 | 0.046 | Carbonic anhydrase VII inhibitor | 0.046 0.033 CID_5897 | CID_5897 | |
| 0.009 | 0.022 | 0.014 | Melatonin 2 antagonist | 0.014 0.006 CID_5897 | CID_5897 | |
| 0.031 | 0.045 | 0.046 | CDK5/p25 inhibitor | 0.046 0.024 CID_5897 | CID_5897 | |
| 0.083 | 0.097 | 0.113 | Protein kinase (CK2) alpha inhibitor | 0.113 0.067 CID_5897 | CID_5897 | |
| 0.013 | 0.03 | 0.024 | Apolipoprotein B-100 inhibitor | 0.024 0.008 CID_5897 | CID_5897 | |
| 0.022 | 0.04 | 0.032 | Purinergic P2Y14 antagonist | 0.032 0.018 CID_5897 | CID_5897 | |
| 0.047 | 0.064 | 0.054 | Sphingosine 1-phosphate receptor 3 antagonist | 0.054 0.049 CID_5897 | CID_5897 | |
| 0.016 | 0.034 | 0.029 | Protease (Human cytomegalovirus) inhibitor | 0.029 0.008 CID_5897 | CID_5897 | |
| 0.049 | 0.069 | 0.07 | 5 Hydroxytryptamine 1B antagonist | 0.07 0.041 CID_5897 | CID_5897 | |
| 0.01 | 0.03 | 0.018 | Carbonic anhydrase VIII inhibitor | 0.018 0.01 CID_5897 | CID_5897 | |
| 0.01 | 0.03 | 0.018 | Carbonic anhydrase X inhibitor | 0.018 0.01 CID_5897 | CID_5897 | |
| 0.064 | 0.086 | 0.076 | Bcr-Abl kinase inhibitor | 0.076 0.069 CID_5897 | CID_5897 | |
| 0.027 | 0.049 | 0.04 | Histone deacetylase 8 inhibitor | 0.04 0.03 CID_5897 | CID_5897 | |
| 0.072 | 0.094 | 0.083 | Protein kinase (CK2) inhibitor | 0.083 0.079 CID_5897 | CID_5897 | |
| 0.022 | 0.045 | 0.044 | Epoxide hydrolase 1 inhibitor | 0.044 0.009 CID_5897 | CID_5897 | |
| 0.02 | 0.043 | 0.033 | Sirtuin 2 inhibitor | 0.033 0.023 CID_5897 | CID_5897 | |
| 0.04 | 0.065 | 0.053 | Potassium channel (Inward rectifier) activator | 0.053 0.029 CID_5897 | CID_5897 | |
| 0.038 | 0.063 | 0.051 | Potassium channel (ATP-sensitive) activator | 0.051 0.028 CID_5897 | CID_5897 | |
| 0.024 | 0.049 | 0.03 | Calcium release-activated channel blocker | 0.03 0.028 CID_5897 | CID_5897 | |
| 0.053 | 0.079 | 0.072 | Histone deacetylase SIRT3 inhibitor | 0.072 0.025 CID_5897 | CID_5897 | |
| 0.074 | 0.11 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | 0.092 0.069 CID_5897 | CID_5897 | |
| 0.032 | 0.07 | 0.061 | Dihydroorotate dehydrogenase inhibitor | 0.061 0.027 CID_5897 | CID_5897 | |
| 0.028 | 0.068 | 0.048 | Cannabinoid CB2 receptor antagonist | 0.048 0.038 CID_5897 | CID_5897 | |
| 0.02 | 0.065 | 0.047 | Melatonin 1 agonist | 0.047 0.01 CID_5897 | CID_5897 | |
| 0.092 | 0.143 | 0.136 | Cytidine deaminase inhibitor | 0.136 0.086 CID_5897 | CID_5897 | |
| 0.083 | 0.136 | 0.174 | M17 leucyl aminopeptidase inhibitor | 0.174 0.043 CID_5897 | CID_5897 | |
| 0.041 | 0.097 | 0.051 | Sphingosine 1-phosphate receptor 1 antagonist | 0.051 0.05 CID_5897 | CID_5897 | |
| 0.183 | 0.242 | 0.301 | DNA directed DNA polymerase inhibitor | 0.301 0.161 CID_5897 | CID_5897 | |
| 0.017 | 0.077 | 0.049 | Melatonin agonist | 0.049 0.01 CID_5897 | CID_5897 | |
| 0.15 | 0.211 | 0.272 | Transcription factor STAT3 inhibitor | 0.272 0.068 CID_5897 | CID_5897 | |
| 0.071 | 0.136 | 0.142 | Histone deacetylase class III inhibitor | 0.142 0.05 CID_5897 | CID_5897 | |
| 0.177 | 0.243 | 0.33 | DNA polymerase beta inhibitor | 0.33 0.149 CID_5897 | CID_5897 | |
| 0.135 | 0.201 | 0.22 | Calpain inhibitor | 0.22 0.095 CID_5897 | CID_5897 | |
| 0.008 | 0.077 | 0.05 | Melatonin 1 antagonist | 0.05 0.005 CID_5897 | CID_5897 | |
| 0.039 | 0.11 | 0.06 | DNA helicase inhibitor | 0.06 0.027 CID_5897 | CID_5897 | |
| 0.069 | 0.141 | 0.097 | Proteasome inhibitor | 0.097 0.092 CID_5897 | CID_5897 | |
| 0.159 | 0.232 | 0.337 | Calpain 2 inhibitor | 0.337 0.093 CID_5897 | CID_5897 | |
| 0.02 | 0.101 | 0.033 | Benzodiazepine receptor peripheral-type antagonist | 0.033 0.025 CID_5897 | CID_5897 | |
| 0.009 | 0.092 | 0.072 | Melatonin antagonist | 0.072 0.005 CID_5897 | CID_5897 | |
| 0.152 | 0.236 | 0.268 | Transcription factor STAT inhibitor | 0.268 0.075 CID_5897 | CID_5897 | |
| 0.054 | 0.143 | 0.071 | Sphingosine 1-phosphate receptor antagonist | 0.071 0.067 CID_5897 | CID_5897 | |
| 0.042 | 0.133 | 0.07 | Epoxide hydrolase inhibitor | 0.07 0.053 CID_5897 | CID_5897 | |
| 0.032 | 0.124 | 0.065 | Prostaglandin-E synthase inhibitor | 0.065 0.055 CID_5897 | CID_5897 | |
| 0.1 | 0.203 | 0.149 | Death-associated protein kinase 1 inhibitor | 0.149 0.041 CID_5897 | CID_5897 | |
| 0.065 | 0.171 | 0.122 | Caspase 3 inhibitor | 0.122 0.057 CID_5897 | CID_5897 | |
| 0.073 | 0.193 | 0.147 | Histone deacetylase SIRT1 inhibitor | 0.147 0.064 CID_5897 | CID_5897 | |
| 0.068 | 0.198 | 0.15 | CDK3/cyclin E inhibitor | 0.15 0.027 CID_5897 | CID_5897 | |
| 0.028 | 0.162 | 0.063 | Amidase inhibitor | 0.063 0.06 CID_5897 | CID_5897 | |
| 0.147 | 0.287 | 0.251 | Transcription factor inhibitor | 0.251 0.186 CID_5897 | CID_5897 | |
| 0.011 | 0.158 | 0.036 | Melatonin 2 agonist | 0.036 0.02 CID_5897 | CID_5897 | |
| 0.029 | 0.177 | 0.077 | Histone deacetylase SIRT2 inhibitor | 0.077 0.048 CID_5897 | CID_5897 | |
| 0.024 | 0.174 | 0.072 | Vanilloid antagonist | 0.072 0.054 CID_5897 | CID_5897 | |
| 0.017 | 0.196 | 0.071 | Neuraminidase (Influenza A) inhibitor | 0.071 0.007 CID_5897 | CID_5897 | |
| 0.034 | 0.256 | 0.081 | ATPase (Vacuolar H+) inhibitor | 0.081 0.077 CID_5897 | CID_5897 | |
| 0.097 | 0.328 | 0.18 | Cyclin-dependent kinase 3 inhibitor | 0.18 0.049 CID_5897 | CID_5897 | |
| 0.085 | 0.328 | 0.195 | Thyroid hormone beta antagonist | 0.195 0.158 CID_5897 | CID_5897 | |
| 0.085 | 0.329 | 0.195 | Thyroid hormone antagonist | 0.195 0.166 CID_5897 | CID_5897 | |
| 0.012 | 0.256 | 0.136 | Neuraminidase inhibitor | 0.136 0.008 CID_5897 | CID_5897 | |
| 0.018 | 0.276 | 0.13 | Neuraminidase (influenza) inhibitor | 0.13 0.01 CID_5897 | CID_5897 | |
| 0.05 | 0.343 | 0.173 | Interleukin antagonist | 0.173 0.101 CID_5897 | CID_5897 | |
| 0.1 | 0.427 | 0.224 | Peptidyltransferase inhibitor | 0.224 0.073 CID_5897 | CID_5897 | |
| 0.007 | 0.39 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | 0.018 0.013 CID_5897 | CID_5897 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |